CONSOLIDATION THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE (HDC) REDUCES MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TREATED WITH FLUDARABINE AS INDUCTION THERAPY
M. Weiss et al., CONSOLIDATION THERAPY WITH HIGH-DOSE CYCLOPHOSPHAMIDE (HDC) REDUCES MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) TREATED WITH FLUDARABINE AS INDUCTION THERAPY, Blood, 88(10), 1996, pp. 1911-1911